(Focus on Type (Polymer, Metal, Ceramic, Natural, Regenerative); Application(Cardiovascular, Orthopaedic, Ophthalmology, Dental, Wound Healing, Plastic Surgery, Neurological, Tissue Engineering)
The global biomaterials market was valued at $72.36 billion in 2016 and is expected to reach $151.65 billion by 2021, growing at a
What is the global biomaterials market size in terms of revenue from 2016-2021?
The global biomaterials market was valued at $72.36 billion in 2016 and is expected to reach $151.65 billion by 2021, growing at a
| 1.1 | Report Scope |
| 1.2 | Global Biomaterials Market Research Methodology |
| 1.2.1 | Assumptions and Limitations |
| 1.2.2 | Primary Research |
| 1.2.3 | Secondary Research |
| 1.2.4 | Data Triangulation |
| 1.2.5 | Data Analyzing and Market Estimation |
| 2.1 | Market Drivers |
| 2.1.1 | Increasing Funds/ Aids by the Government For Research Purposes |
| 2.1.2 | Increasing Plastic Surgery and Wound Healing Therapies |
| 2.1.3 | Increasing Aging/Geriatric Population |
| 2.1.4 | Rise in Prevalence of Cardiovascular Diseases |
| 2.1.5 | Increasing Orthopaedic Disorders |
| 2.1.6 | Growing Demand for Implantable Devices |
| 2.1.7 | Increasing Awareness of Regenerative Medicine |
| 2.2 | Market Restraints/Challenges |
| 2.2.1 | Biocompatibility Issues and Safety and Stringent Regulations |
| 2.2.2 | Limitations of Biomaterial-Based Products |
| 2.3 | Market Opportunities |
| 2.3.1 | Increasing Obesity |
| 2.3.2 | Patient Awareness and Improved Lifestyle in Emerging Economies |
| 2.3.3 | Introduction of Biomaterials in Cancer Research |
| 2.4 | Key Trends in the Biomaterials Market |
| 3.1 | Competitive Analysis |
| 3.1.1 | Biomaterials Market Competitive Analysis |
| 3.2 | Opportunity Matrix Analysis |
| 3.3 | Country Share Analysis |
| 3.4 | Biomaterials in Research & Development |
| 3.5 | R&D Analysis of Key Market Players |
| 3.6 | Key Strategies and Developments |
| 3.6.1 | Agreements, Collaborations, Contracts, Joint Venture, & Partnerships |
| 3.6.2 | Business Expansions |
| 3.6.3 | New Product Launches & Developments |
| 3.6.4 | Mergers & Acquisitions |
| 3.6.5 | Others |
| 4.1 | Supply Chain Analysis |
| 4.2 | Porter’s Five Forces Analysis |
| 4.2.1 | Threat of New Entrants |
| 4.2.2 | Threat of Substitutes |
| 4.2.3 | Bargaining Power of Buyers |
| 4.2.4 | Bargaining Power of Suppliers |
| 4.2.5 | Intensity of Competitive Rivalry |
| 4.3 | Future Trends and Developments in Biomaterials Market |
| 5.1 | Metals |
| 5.1.1 | Stainless Steel |
| 5.1.2 | Titanium and Titanium alloys |
| 5.1.3 | Co-Cr Alloys |
| 5.1.4 | Magnesium |
| 5.1.5 | Gold |
| 5.1.6 | Silver |
| 5.1.7 | Nitinol |
| 5.1.8 | Other Metal Based Biomaterials |
| 5.2 | Polymer Based Biomaterials |
| 5.2.1 | Polyethylene Terephthalate (PET) |
| 5.2.2 | Polypropylene (PP) |
| 5.2.3 | Polyetheretherketone (PEEK) |
| 5.2.4 | Ultra-High Molecular Weight Polyethylene (UHMWPE) |
| 5.2.5 | Polytetrafluoroethylene (PTFE) |
| 5.2.6 | Polyglycolide (PGA) |
| 5.2.7 | Polyactide (PLA) |
| 5.2.8 | Polycaprolactone (PCL) |
| 5.2.9 | Polyglycerol Sebacate (PGS) |
| 5.2.10 | Polyvinylchloride (PVC) |
| 5.2.11 | Silicone Rubber |
| 5.2.12 | Nylon |
| 5.2.13 | Polymethyl Methacrylate (PMMA) |
| 5.2.14 | Other Polymers |
| 5.3 | Ceramic Based Biomaterials |
| 5.3.1 | Alumina |
| 5.3.2 | Calcium Phosphate |
| 5.3.3 | Zirconia |
| 5.3.4 | Calcium Sulphate |
| 5.3.5 | Carbon |
| 5.3.6 | Other Ceramic Based Biomaterials |
| 5.4 | Natural Based Biomaterials |
| 5.4.1 | Collagen |
| 5.4.2 | Fibrin |
| 5.4.3 | Gelatin |
| 5.4.4 | Silk |
| 5.4.5 | Alginates |
| 5.4.6 | Hyaluronic Acid |
| 5.4.7 | Chitin |
| 5.4.8 | Cellulose |
| 5.5 | Inorganic Glass Based Biomaterials |
| 5.5.1 | Silicates |
| 5.5.2 | Bioactive Glass |
| 5.5.3 | Phosphate |
| 5.6 | Radiopaque Biomaterials |
| 5.7 | Regenerative Biomaterials |
| 5.8 | Hybrid Biomaterial Combinations |
| 6.1 | Cardiovascular |
| 6.1.1 | Catheters |
| 6.1.2 | Stents |
| 6.1.3 | Heart Valves |
| 6.1.4 | Guidewires |
| 6.1.5 | Sensors |
| 6.1.6 | Pacemaker |
| 6.1.7 | Implantable Cardiac Defibrillators |
| 6.1.8 | Vascular Grafts |
| 6.2 | Orthopaedic |
| 6.2.1 | Joint Replacement |
| 6.2.1.1 | Hip Replacements |
| 6.2.1.2 | Knee Replacements |
| 6.2.1.3 | Shoulder Replacements |
| 6.2.1.4 | Other Replacements |
| 6.2.2 | Viscossupplementation |
| 6.2.3 | Bioresorbable Tissue Fixation |
| 6.2.3.1 | Suture Anchors |
| 6.2.3.2 | Interference Screws |
| 6.2.3.3 | Meshes |
| 6.2.4 | Spine |
| 6.2.4.1 | Minimally Invasive Fusion Surgeries |
| 6.2.4.2 | Motion Preservation and Dynamic Stabilization |
| 6.2.4.2.1 | Pedicle Based Rod Systems |
| 6.2.4.2.2 | Interspinous Spacers |
| 6.2.4.2.3 | Disc Arthoplasty/Replacement |
| 6.2.5 | Fracture Fixation |
| 6.2.5.1 | Bone Plates |
| 6.2.5.2 | Screws |
| 6.2.5.3 | Pins |
| 6.2.5.4 | Rods |
| 6.2.6 | Orthobiology |
| 6.2.6.1 | Bone Grafts |
| 6.3 | Ophthalmology |
| 6.3.1 | Contact Lenses |
| 6.3.2 | Intraocular Lenses |
| 6.3.3 | Functional Replacement of Ocular Tissues |
| 6.3.4 | Synthetic Corneas |
| 6.3.5 | Others |
| 6.4 | Dental |
| 6.4.1 | Dental Bone Grafts and Substitutes |
| 6.4.2 | Dental Membranes |
| 6.5 | Wound Healing |
| 6.5.1 | Wound Closure Devices |
| 6.5.2 | Sutures |
| 6.5.3 | Staples |
| 6.5.4 | Surgical Haemostats |
| 6.5.5 | Internatal Tissue Sealants |
| 6.5.6 | Adhesion Barriers |
| 6.5.7 | Hernia Meshes |
| 6.6 | Plastic Surgery |
| 6.6.1 | Soft-Tissue Fillers |
| 6.6.2 | Craniofacial Surgery |
| 6.7 | Neurological/Central Nervous System |
| 6.7.1 | Shunting Systems |
| 6.7.2 | Cortical Neural Prosthetics (CNP) |
| 6.7.3 | Hydrogel Scaffolds for CNS Report |
| 6.7.4 | Neural Stem Cell Encapsulation |
| 6.8 | Tissue Engineering |
| 6.8.1 | Scaffolds for Regenerative Medicine |
| 6.8.2 | Nanomaterial for Biosensing |
| 6.8.3 | Tailoring of Inorganic Nanoparticles |
| 6.9 | Others |
| 6.9.1 | Drug Delivery Systems |
| 6.9.2 | Gastrointestinal Applications |
| 6.9.3 | Bariatric Surgery |
| 6.9.4 | Urinary Applications |
| 7.1 | North America |
| 7.1.1 | Biomaterials Market, by Type |
| 7.1.2 | Biomaterials Market, by Application |
| 7.1.3 | Biomaterials Market, by Country |
| 7.1.3.1 | The U.S. |
| 7.1.3.1.1 | Biomaterials-Based Research in the U.S |
| 7.1.3.1.2 | Growing Demand for Plastic Surgeries in the U.S. |
| 7.1.3.1.3 | Conferences and Symposiums on Biomaterials in the U.S. |
| 7.1.3.1.4 | Increase in Cancer Incidence |
| 7.1.3.1.5 | Growing Prevalence of Cardiovascular Diseases |
| 7.1.3.1.6 | Regulations in the U.S. |
| 7.1.3.2 | Canada |
| 7.1.3.2.1 | Growth in the Aging Population |
| 7.1.3.2.2 | Growing Development Activities for Biomaterials in Canada |
| 7.1.3.3 | Mexico |
| 7.1.3.3.1 | Growing R&D activity for Biomaterials in Mexico |
| 7.1.3.3.2 | Emergence of Dental Growth |
| 7.2 | Europe |
| 7.2.1 | Biomaterials Market, by Type |
| 7.2.2 | Biomaterials Market, by Application |
| 7.2.3 | Biomaterials Market, by Country |
| 7.2.3.1 | Germany |
| 7.2.3.2 | The U.K. |
| 7.2.3.3 | France |
| 7.2.3.4 | Spain |
| 7.2.3.5 | Italy |
| 7.2.3.6 | Russia |
| 7.2.3.7 | Rest of Europe(RoE) |
| 7.3 | Asia Pacific |
| 7.3.1 | Biomaterials Market, by Type |
| 7.3.2 | Biomaterials Market, by Application |
| 7.3.3 | Biomaterials Market, by Country |
| 7.3.3.1 | China |
| 7.3.3.2 | Japan |
| 7.3.3.3 | India |
| 7.3.3.4 | South Korea |
| 7.3.3.5 | Rest of Asia Pacific |
| 7.4 | Middle East & Africa |
| 7.4.1 | Biomaterials Market, by Type |
| 7.5 | South America |
| 7.5.1 | Biomaterials Market, by Type |
| 8.1 | BASF SE |
| 8.1.1 | Company Overview |
| 8.1.2 | Financials |
| 8.1.2.1 | Financial Summary |
| 8.1.3 | BASF SE: SWOT Analysis |
| 8.2 | Bioactive Bone Substitutes Ltd. |
| 8.2.1 | Company Overview |
| 8.2.2 | About the Company |
| 8.3 | Berkeley Advanced Biomaterials Inc. |
| 8.3.1 | Company Overview |
| 8.3.2 | Product Portfolio |
| 8.3.3 | About the Company |
| 8.4 | Bioretec Ltd. |
| 8.4.1 | Company Overview |
| 8.4.2 | About the Company |
| 8.5 | CAM Bioceramics B.V. |
| 8.5.1 | Company Overview |
| 8.5.2 | About the Company |
| 8.6 | Carpenter Technology Corporation |
| 8.6.1 | Company Overview |
| 8.6.2 | Product Portfolio |
| 8.6.3 | Overall Financials |
| 8.6.3.1 | Financial Summary |
| 8.6.4 | SWOT Analysis |
| 8.7 | Celanese Corporation |
| 8.7.1 | Company Overview |
| 8.7.2 | Product Portfolio |
| 8.7.3 | Financials |
| 8.7.3.1 | Financial Summary |
| 8.7.4 | SWOT Analysis |
| 8.8 | Collagen Solutions |
| 8.8.1 | Company Overview |
| 8.8.2 | Product Portfolio |
| 8.8.3 | Overall Financials |
| 8.8.3.1 | Financial Summary |
| 8.8.4 | SWOT Analysis |
| 8.9 | Corbion N.V. |
| 8.9.1 | Company Overview |
| 8.9.2 | Overall Financials: |
| 8.9.2.1 | Financial Summary |
| 8.9.3 | SWOT Analysis |
| 8.1 | Covestro AG |
| 8.10.1 | Company Overview |
| 8.10.2 | Product Portfolio |
| 8.10.3 | Overall Financials: |
| 8.10.3.1 | Financial Summary |
| 8.10.4 | SWOT Analysis |
| 8.11 | Koninklijke DSM N.V. |
| 8.11.1 | Company Overview |
| 8.11.2 | Product Portfolio |
| 8.11.3 | Overall Financials: |
| 8.11.3.1 | Financial Summary |
| 8.11.4 | SWOT Analysis |
| 8.12 | Evonik Industries |
| 8.12.1 | Company Overview |
| 8.12.2 | Product Portfolio |
| 8.12.3 | Overall Financials: |
| 8.12.3.1 | Financial Summary |
| 8.12.4 | SWOT Analysis |
| 8.13 | Invibio Biomaterial Solutions |
| 8.13.1 | Company Overview |
| 8.13.2 | About the Company |
| 8.14 | Regentis Biomaterials |
| 8.14.1 | Company Overview |
| 8.14.2 | About the Company |
| 8.15 | Zimmer Biomet Holdings Inc. |
| 8.15.1 | Company Overview |
| 8.15.2 | Product Portfolio |
| 8.15.3 | Overall Financials: |
| 8.15.3.1 | Financial Summary |
| 8.15.4 | SWOT Analysis |
| Table 1 | Global Biomaterials Market Snapshot, 2017 and 2021 |
| Table 3.1 | Biomaterials Market Competitive Analysis, by Revenue, 2016 |
| Table 3.2 | Agreements, Contracts, Collaborations, Joint Ventures & Partnerships |
| Table 3.3 | Key Business Expansion Activities |
| Table 3.4 | Key Product Launches |
| Table 3.5 | Key Mergers & Acquisitions |
| Table 3.6 | Other Developments |
| Table 5.1 | Global Biomaterials Market, by Type, (2016 – 2021) |
| Table 5.2 | Metal based Biomaterials used in the Biomedical Application |
| Table 5.3 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.4 | Synthetic and Natural Polymers Used in Biomedical Applications |
| Table 5.5 | PEEK Based biomaterials |
| Table 5.6 | Global Metal Based Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.7 | Properties of Polymers Needed for Specific Biomaterials Applications |
| Table 5.8 | Overview of Ceramic based Biomaterials Market |
| Table 5.9 | Global Ceramic Based Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.10 | Different Types of Ceramic Needed for Biomaterial Applications |
| Table 5.11 | Collagen Biomaterials Market, by Region, 2016-2021 |
| Table 5.12 | Global Inorganic Based Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.13 | Global Radiopaque Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.14 | Global Regenerative Biomaterials Market, by Region, (2016 – 2021) |
| Table 5.15 | Global Hybrid Biomaterials Combinations Market, by Region, (2016 – 2021) |
| Table 6.1 | Application Overview of Biomaterials, by Devices |
| Table 6.2 | Global Biomaterials Market, by Application, (2016 – 2021) |
| Table 6.3 | Biomaterials used in Cardiovascular system |
| Table 6.4 | Cardiovascular Biomaterials Market, by Medical Devices, (2016 – 2021) |
| Table 6.5 | Cardiovascular Biomaterials Market, by Region, (2016 – 2021) |
| Table 6.6 | Factors Leading to the Cardiovascular Diseases in North America |
| Table 6.7 | Biomaterials used in Orthopedic Applications |
| Table 6.8 | Orthopedic Biomaterials Market, by Sub-Application, (2016 – 2021) |
| Table 6.9 | Past vs. Present Materials used in Hip, Shoulder, and Knee Replacements |
| Table 6.10 | Joint Replacement Orthopedic Biomaterials Materials Market, by Type, (2016 – 2021) |
| Table 6.11 | FDA Approved Injectable HA Viscossupplementation Products |
| Table 6.12 | Degradation Time of Biomaterials Used in Bioabsorbable Suture Anchors |
| Table 6.13 | Degradation Time of Biomaterials used in Biresorbable Suture Anchors |
| Table 6.14 | Orthopedic Biomaterials Market, by Region, (2016 – 2021) |
| Table 6.15 | Ophthalmology Biomaterials Market, by Region, (2016 – 2021) |
| Table 6.16 | Dental Biomaterials Market, by Region, (2016-2021) |
| Table 6.17 | Wound Healing Biomaterials Market, by Region (2016-2021) |
| Table 6.18 | Surgical Procedures Performed for Plastic Surgery, By Country, 2015 |
| Table 6.19 | Non-Surgical Procedures Performed for Plastic Surgery, By Country, 2015 |
| Table 6.20 | Plastic Surgery Biomaterials Market, by Region (2016-2021) |
| Table 6.21 | Neurological/Central Nervous System Biomaterials Market, by Region (2016-2021) |
| Table 6.22 | Tissue Engineering Biomaterials Market, by Region (2016-2021) |
| Table 6.23 | Other Applications Biomaterials Market, by Region (2016-2021) |
| Table 7.1 | Global Biomaterials Market, by Region, (2016 – 2021) |
| Table 7.2 | North American Biomaterials Market, by Type, (2016 – 2021) |
| Table 7.3 | North America Biomaterials Market, by Application, (2016 – 2021) |
| Table 7.4 | North American Biomaterials Market by Country, (2016 – 2021) |
| Table 7.5 | The U.S. Biomaterials Market, by Application, (2016–2021) |
| Table 7.6 | Canadian Population on Basis of Age above 65, 1851 to 2041 |
| Table 7.7 | Canadian Biomaterials Market, by Application, 2017-2021 |
| Table 7.8 | Mexico Biomaterials Market, by Application, 2017-2021 |
| Table 7.9 | European Biomaterials Market (2016-2021), by Type |
| Table 7.10 | European Biomaterials Market, by Application, (2016-2021) |
| Table 7.11 | European Biomaterials Market by Country, (2016 – 2021) |
| Table 7.12 | German Biomaterials Market, by Application, (2016–2021) |
| Table 7.13 | The U.K. Biomaterials Market, by Application, (2016–2021) |
| Table 7.14 | France Biomaterials Market, by Application, (2016–2021) |
| Table 7.15 | Spain Biomaterials Market, by Application, (2016–2021) |
| Table 7.16 | Italy Biomaterials Market, by Application, (2016–2021) |
| Table 7.17 | Russian Biomaterials Market, by Application, (2016–2021) |
| Table 7.18 | Rest of Europe Biomaterials Market, by Application, (2016–2021) |
| Table 7.19 | Asia-Pacific Biomaterials Market, by Type, (2016-2021) |
| Table 7.20 | Asia-Pacific Biomaterials Market, by Application, (2016 – 2021) |
| Table 7.21 | Asia-Pacific Biomaterials Market by Country, (2016 – 2021) |
| Table 7.22 | China Biomaterials Market, by Application, (2016–2021) |
| Table 7.23 | Japan Biomaterials Market, by Application, (2016–2021) |
| Table 7.24 | India Biomaterials Market, by Application, (2016–2021) |
| Table 7.25 | South Korean Biomaterials Market, by Application, 2016-2021 |
| Table 7.26 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 |
| Table 7.27 | Middle East & Africa Biomaterials Market, by Type, (2016 – 2021) |
| Table 7.28 | Middle East & Africa Biomaterials Market, by Application, (2016 – 2021) |
| Table 7.29 | South American Biomaterials Market, by Type, (2016 – 2021) |
| Table 7.30 | South American Biomaterials Market, by Application, (2016 – 2021) |
| Figure 1 | Evolution of Biomaterials |
| Figure 2 | Global Biomaterials Market Snapshot, 2016-2021 |
| Figure 3 | Global Biomaterials Market Share and Size, by Type, 2017 and 2021 |
| Figure 4 | Global Biomaterials Market Share, by Application: 2017 & 2021 |
| Figure 5 | Global Biomaterials Market, by Region, 2017 and 2021 |
| Figure 6 | Global Biomaterials Market, by Country, 2016 and 2021 |
| Figure 1.1 | Global Biomaterials Market Scope |
| Figure 1.2 | Report Design |
| Figure 1.3 | Sources of Secondary Research |
| Figure 1.4 | Data Triangulation |
| Figure 1.5 | Top Down & Bottom Up Approach |
| Figure 2.1 | Global Biomaterials Market Dynamics |
| Figure 2.2 | Number of Plastic Surgery Procedures and Percentage Share, by Country, 2014 |
| Figure 2.3 | Number of Plastic Surgery Procedures in the U.S., by Type, 2015 |
| Figure 2.4 | Global Percentage of Aging Population |
| Figure 2.5 | Global Percentage of Aging Population |
| Figure 2.6 | Cardiovascular Disease Death Rates, By Country, 2014 |
| Figure 2.7 | Key Facts about Joint Replacement (2014-2015) |
| Figure 2.8 | Global Medical Implants, by Application |
| Figure 2.9 | Medical Implants in the Human Body |
| Figure 2.10 | Key Trends in the Biomaterials Market |
| Figure 3.1 | Global Biomaterials Market Opportunity Matrix, by Region, 2016 |
| Figure 3.2 | Global Biomaterials Market Opportunity Matrix, by Country, 2016 |
| Figure 3.3 | Global Biomaterials Market Opportunity Matrix, by Country, 2021 |
| Figure 3.4 | Country Share Analysis of Global Biomaterials Market, 2016 |
| Figure 3.5 | R&D Focus Areas of Axio Bio |
| Figure 3.6 | R&D Analysis of Key Market Players |
| Figure 3.7 | Share of Key Market Strategies & Developments |
| Figure 3.8 | Total Number of Strategies & Developments |
| Figure 4.1 | Supply Chain Analysis of Biomaterials Market |
| Figure 4.2 | Biomaterial Science and a Path from a Need to Manufactured Medical Device |
| Figure 4.3 | Porter’s Five Forces Analysis of Biomaterials Market |
| Figure 4.4 | Future Trends and Developments in the Biomaterials Market |
| Figure 5.1 | Global Biomaterials Market Size, by Type, 2017 and 2021 |
| Figure 5.2 | Global Biomaterials Market, by Type, 2016-2021 |
| Figure 5.3 | Global Biomaterials Market Share, by Type, 2016-2021 |
| Figure 5.4 | Different Types of Biomaterials in Different Applications |
| Figure 5.5 | Global Metal based Biomaterials Market Size, (2016 – 2021) |
| Figure 5.6 | Evolution of Gold based Biomaterials in Medical Applications |
| Figure 5.7 | Application Overview of Gold |
| Figure 5.8 | Application Overview of Nitinol Based Biomaterials |
| Figure 5.9 | Alloy Composition of Nitinol |
| Figure 5.10 | Global Metal Based Biomaterials Market, by Region, 2016-2021 |
| Figure 5.11 | Global Polymer Based Biomaterials Market, 2017-2021 |
| Figure 5.12 | Polymer based Biomaterials Market, by Region, 2016-2021 |
| Figure 5.13 | Global Ceramic Based Biomaterials Market, 2017-2021 |
| Figure 5.14 | Ceramic Based Biomaterials Market, by Region, 2016-2021 |
| Figure 5.15 | Global Natural Biomaterials Market, 2017-2021 |
| Figure 5.16 | Collagen Biomaterials Market, by Region, 2016-2021 |
| Figure 5.17 | Properties of Inorganic Glass |
| Figure 5.18 | Inorganic Glass Based Biomaterials Market, by Region, 2016-2021 |
| Figure 5.19 | History of Calcium Phosphate Based Biomaterials |
| Figure 5.20 | Inorganic Based Biomaterials Market, by Region, 2016-2021 |
| Figure 5.21 | Global Radiopaque Biomaterials Market, 2017-2021 |
| Figure 5.22 | Radiopaque Biomaterials Market, by Region, 2016-2021 |
| Figure 5.23 | Regenerative Biomaterials Market, by Region, 2016-2021 |
| Figure 5.24 | Global Hybrid Biomaterial Combinations Market, 2017-2021 |
| Figure 5.25 | Hybrid Biomaterial Combinations Market, by Region, 2016-2021 |
| Figure 6.1 | Global Biomaterials Market, by Application |
| Figure 6.2 | Global Biomaterials Market, by Application, 2017 and 2021 |
| Figure 6.3 | Medical Devices and their Blood Contact Time |
| Figure 6.4 | Number of Procedures in Joint Construction, 2016 |
| Figure 6.5 | Global Ophthalmology Biomaterials Market, 2017-2021 |
| Figure 6.6 | Properties of Polymer Based Biomaterials in Ophthalmology |
| Figure 6.7 | Percent Share of Contact Lenses, by Region, 2014 |
| Figure 6.8 | Global Dental Biomaterials Market, (2016-2021) |
| Figure 6.9 | Key Facts and Figures on Dental Implantation in America |
| Figure 6.10 | Global Wound Healing Biomaterials Market, (2016 – 2021) |
| Figure 6.11 | Global Plastic Surgery Biomaterials Market, (2016 – 2021) |
| Figure 6.12 | Global Neurological/Central Nervous System Biomaterials Market, (2016 – 2021) |
| Figure 6.13 | Formation Engineered Tissue |
| Figure 6.14 | Global Tissue Engineering Biomaterials Market, (2016 – 2021) |
| Figure 6.15 | Properties of Biomaterial Scaffolds |
| Figure 6.16 | Global Other Applications Biomaterials Market, (2016 – 2021) |
| Figure 7.1 | Biomaterials Market Growth Rate, by Region |
| Figure 7.2 | Biomaterials Market Growth Rate, by Region, 2017 and 2021 |
| Figure 7.3 | North American Biomaterials Market Snapshot, 2016-2021 |
| Figure 7.4 | Factors Driving the Biomaterials Market in North American Biomaterials, 2017 and 2021 |
| Figure 7.5 | North American Distribution of Orthopedic Surgery Procedures, 2015 |
| Figure 7.6 | Surgical Procedures in North America, 2015 and 2016 |
| Figure 7.7 | Non-Surgical Procedures in North America, 2015 and 2016 |
| Figure 7.8 | The U.S. Biomaterials Market, by Application, 2017-2021 |
| Figure 7.9 | Increase in Plastic Surgeries in the U.S. from 2000 to 2015 |
| Figure 7.10 | Cancer Cases and Death Estimation in the U.S., 2017 |
| Figure 7.11 | Facts and Risks Associated with Cardiovascular Diseases in the U.S. |
| Figure 7.12 | Canadian Biomaterials Market, by Application, 2017-2021 |
| Figure 7.13 | Facts and Risks associated with Cardiovascular Diseases in the Canada |
| Figure 7.14 | Mexico Biomaterials Market, by Application, 2017-2021 |
| Figure 7.15 | Global European Biomaterials Market, 2017-2021 |
| Figure 7.16 | Factors Driving the Biomaterials Market in European Biomaterials, 2017 and 2021 |
| Figure 7.17 | Percent Share of different Kind of Diseases in Europe, by Male and Female, 2016 |
| Figure 7.18 | German Biomaterials Market, by Application, 2017-2021 |
| Figure 7.19 | The U.K. Biomaterials Market, by Application, 2017-2021 |
| Figure 7.20 | Common Plastic Surgery Procedure in the U.K. |
| Figure 7.21 | France Biomaterials Market, by Application, 2017-2021 |
| Figure 7.22 | Spain Biomaterials Market, by Application, 2017-2021 |
| Figure 7.23 | Italy Biomaterials Market, by Application, 2017-2021 |
| Figure 7.24 | Russia Biomaterials Market, by Application, 2017-2021 |
| Figure 7.25 | Rest of Europe Biomaterials Market, by Application, 2017-2021 |
| Figure 7.26 | Asia-Pacific Biomaterials Market Snapshot, 2016-2021 |
| Figure 7.27 | Factors Driving the Biomaterials Market in Asia-Pacific, 2017 and 2021 |
| Figure 7.28 | China Biomaterials Market, by Application, 2017-2021 |
| Figure 7.29 | Japan Biomaterials Market, by Application, 2017-2021 |
| Figure 7.30 | India Biomaterials Market, by Application, 2017-2021 |
| Figure 7.31 | Percentage of Heart Attack among Indians for Different Age Groups |
| Figure 7.32 | South Korean Biomaterials Market, by Application, 2017-2021 |
| Figure 7.33 | Indonesian Medical Device Regulation System |
| Figure 7.34 | Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 |
| Figure 7.35 | Middle East & Africa Biomaterials Market, 2017-2021 |
| Figure 7.36 | South American Biomaterials Market, by Type, 2017-2021 |
| Figure 8.1 | BASF SE: Overall Financials, 2014-2016 |
| Figure 8.2 | BASF SE: Geographic Revenue Mix, 2014-2016 |
| Figure 8.3 | BASF SE: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.4 | Carpenter Technology Corporation: Overall Financials, 2014-2016 |
| Figure 8.5 | Carpenter Technology Corporation: Geographic Revenue Mix, 2014-2016 |
| Figure 8.6 | Carpenter Technology Corporation: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.7 | Celanese Corporation: Overall Financials, 2014-2016 |
| Figure 8.8 | Celanese Corporation: Geographic Revenue Mix, 2014-2016 |
| Figure 8.9 | Celanese Corporation: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.10 | Collagen Solutions: Overall Financials, 2014-2016 |
| Figure 8.11 | Collagen Solutions: Geographic Revenue Mix, 2014-2016 |
| Figure 8.12 | Corbion N.V.: Overall Financials, 2014-2016 |
| Figure 8.13 | Corbion N.V.: Geographic Revenue Mix, 2014-2016 |
| Figure 8.14 | Corbion N.V.: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.15 | Corbion N.V.: Biochemical Sub-Segment Revenue Mix, 2014-2016 |
| Figure 8.16 | Covestro AG: Overall Financials, 2014-2016 |
| Figure 8.17 | Covestro AG: Geographic Revenue Mix, 2014-2016 |
| Figure 8.18 | Covestro AG: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.19 | Koninklijke DSM N.V.: Overall Financials, 2014-2016 |
| Figure 8.20 | Koninklijke DSM N.V.: Geographic Revenue Mix, 2014-2016 |
| Figure 8.21 | Koninklijke DSM N.V.: Business Segment Revenue Mix, 2013-2015 |
| Figure 8.22 | Evonik Industries: Overall Financials, 2014-2016 |
| Figure 8.23 | Evonik Industries: Geographic Revenue Mix, 2014-2016 |
| Figure 8.24 | Evonik Industries: Business Segment Revenue Mix, 2014-2016 |
| Figure 8.25 | Zimmer Biomet Holdings Inc.: Overall Financials, 2014-2016 |
| Figure 8.26 | Zimmer Biomet Holdings Inc.: Geographic Revenue Mix, 2014-2016 |
| Figure 8.27 | Zimmer Biomet Holdings Inc.: Business Segment Revenue Mix, 2014-2016 |
The global lightweight materials market in terms of value is estimated to witness a growth at...
In 2015, the global 3D bio printer market generated total market size of $148.5 million and...
(Focus on Type (Polymer, Metal, Ceramic, Natural, Regenerative); Application(Cardiovascular, Orthopaedic, Ophthalmology, Dental, Wound Healing, Plastic Surgery, Neurological, Tissue Engineering)
